HTA - 09/91/21

A Randomised Multi-Stage Phase II/III Trial of Standard first-line therapy (sunitinib or pazopanib) Comparing Temporary Cessation with Allowing continuation, in the treatment of locally advanced and/or metastatic Renal Cancer (the STAR trial)

Project title: A Randomised Multi-Stage Phase II/III Trial of Standard first-line therapy (sunitinib or pazopanib) Comparing Temporary Cessation with Allowing continuation, in the treatment of locally advanced and/or metastatic Renal Cancer (the STAR trial)

Chief investigator: Professor Janet Brown

Contractor: University of Leeds

Co-investigators: Dr Barbara Potrata, Dr Fiona Collinson, Dr Helen Howard, Dr Pat Harnden, Dr Patrick Hanlon, Dr Tze Min Wah, Mrs Kate Hayward, Professor Anthony Maraveyas, Professor Christopher McCabe, Professor Jenny Hewison, Professor Julia Brown, Professor Peter Selby, Professor Rob Jones, Professor Rosamonde Banks, Professor Tim Eisen, Professor Vicky Goh, Professor Walter Gregory.

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.